CARDLYTICS, INC. Research and Development Expense
CARDLYTICS, INC. (CDLX) reported Research and Development Expense of $5.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- CARDLYTICS, INC. research and development expense for the quarter ending 2026-06-30 was $5.54M, a 43.85% decline year-over-year.
- CARDLYTICS, INC. research and development expense for the quarter ending 2026-03-31 was $6.43M, a 37.44% decline year-over-year.
- CARDLYTICS, INC. research and development expense for the quarter ending 2025-12-31 was $7.96M, a 19.50% decline year-over-year.
- CARDLYTICS, INC. research and development expense for the quarter ending 2025-09-30 was $8.80M, a 33.31% decline year-over-year.
- CARDLYTICS, INC. research and development expense for fiscal 2025 was $39.77M, a 19.84% decline from fiscal 2024.
- CARDLYTICS, INC. research and development expense for fiscal 2024 was $49.61M, a 3.40% decline from fiscal 2023.
- CARDLYTICS, INC. research and development expense for fiscal 2023 was $51.35M, a 5.66% decline from fiscal 2022.
- CARDLYTICS, INC. research and development expense for fiscal 2022 was $54.44M, a 42.86% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5.54M 10-Q · filed 2026-08-05 | $11.97M 10-Q · filed 2026-08-05 | $19.93M derived: sum of 3 quarters · filed 2026-08-05 | $28.73M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $6.43M 10-Q · filed 2026-05-07 | $14.39M derived: sum of 2 quarters · filed 2026-05-07 | $23.19M derived: sum of 3 quarters · filed 2026-05-07 | $33.06M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $7.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $16.76M derived: sum of 2 quarters · filed 2026-03-04 | $26.63M derived: sum of 3 quarters · filed 2026-08-05 | $39.77M 10-K · filed 2026-03-04 | ||
| 2025-09-30 | $8.80M 10-Q · filed 2025-11-05 | $18.67M derived: sum of 2 quarters · filed 2026-08-05 | $31.80M 10-Q · filed 2025-11-05 | $38.84M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $9.87M 10-Q · filed 2026-08-05 | $11.29M 10-Q · filed 2025-08-06 | $20.14M 10-Q · filed 2026-08-05 | $23.00M 10-Q · filed 2025-08-06 | $30.04M derived: sum of 3 quarters · filed 2026-08-05 | $43.23M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $10.28M 10-Q · filed 2026-05-07 | $11.71M 10-Q · filed 2025-05-07 | $20.17M derived: sum of 2 quarters · filed 2026-05-07 | $33.37M derived: sum of 3 quarters · filed 2026-05-07 | $46.84M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $9.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $23.09M derived: sum of 2 quarters · filed 2026-03-04 | $36.56M derived: sum of 3 quarters · filed 2026-03-04 | $49.61M 10-K · filed 2026-03-04 | ||
| 2024-09-30 | $13.19M 10-Q · filed 2025-11-05 | $26.66M derived: sum of 2 quarters · filed 2025-11-05 | $39.71M 10-Q · filed 2025-11-05 | $52.22M derived: sum of 4 quarters · filed 2026-03-04 | ||
| 2024-06-30 | $13.47M 10-Q · filed 2025-08-06 | $26.52M 10-Q · filed 2025-08-06 | $39.03M derived: sum of 3 quarters · filed 2026-03-04 | $51.46M derived: sum of 4 quarters · filed 2026-03-04 | ||
| 2024-03-31 | $13.05M 10-Q · filed 2025-05-07 | $25.56M derived: sum of 2 quarters · filed 2026-03-04 | $37.99M derived: sum of 3 quarters · filed 2026-03-04 | $52.84M derived: sum of 4 quarters · filed 2026-03-04 | ||
| 2023-12-31 | $12.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $24.94M derived: sum of 2 quarters · filed 2026-03-04 | $39.79M derived: sum of 3 quarters · filed 2026-03-04 | $51.35M 10-K · filed 2026-03-04 | ||
| 2023-09-30 | $12.43M 10-Q · filed 2024-11-06 | $27.28M derived: sum of 2 quarters · filed 2024-11-06 | $38.84M 10-Q · filed 2024-11-06 | $53.64M derived: sum of 4 quarters · filed 2025-03-12 | ||
| 2023-06-30 | $14.85M 10-Q · filed 2024-08-07 | $26.41M 10-Q · filed 2024-08-07 | $41.21M derived: sum of 3 quarters · filed 2025-03-12 | $54.97M derived: sum of 4 quarters · filed 2025-03-12 | ||
| 2023-03-31 | $11.56M 10-Q · filed 2024-05-08 | $26.36M derived: sum of 2 quarters · filed 2025-03-12 | $40.13M derived: sum of 3 quarters · filed 2025-03-12 | $53.71M derived: sum of 4 quarters · filed 2025-03-12 | ||
| 2022-12-31 | $14.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $28.56M derived: sum of 2 quarters · filed 2025-03-12 | $42.14M derived: sum of 3 quarters · filed 2025-03-12 | $54.44M 10-K · filed 2025-03-12 | ||
| 2022-09-30 | $13.76M 10-Q · filed 2023-11-08 | $27.34M derived: sum of 2 quarters · filed 2023-11-08 | $39.63M 10-Q · filed 2023-11-08 | $51.45M derived: sum of 4 quarters · filed 2024-03-14 | ||
| 2022-06-30 | $13.58M 10-Q · filed 2023-08-01 | $25.87M 10-Q · filed 2023-08-01 | $37.68M derived: sum of 3 quarters · filed 2024-03-14 | $48.82M derived: sum of 4 quarters · filed 2024-03-14 | ||
| 2022-03-31 | $12.29M 10-Q · filed 2023-05-04 | $24.10M derived: sum of 2 quarters · filed 2024-03-14 | $35.24M derived: sum of 3 quarters · filed 2024-03-14 | $44.18M derived: sum of 4 quarters · filed 2024-03-14 | ||
| 2021-12-31 | $11.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $22.95M derived: sum of 2 quarters · filed 2024-03-14 | $31.89M derived: sum of 3 quarters · filed 2024-03-14 | $38.10M 10-K · filed 2024-03-14 | ||
| 2021-09-30 | $11.14M 10-Q · filed 2022-11-01 | $20.07M derived: sum of 2 quarters · filed 2022-11-01 | $26.29M 10-Q · filed 2022-11-01 | $31.38M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $8.93M 10-Q · filed 2022-08-02 | $15.15M 10-Q · filed 2022-08-02 | $20.24M derived: sum of 3 quarters · filed 2023-03-01 | $24.87M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $6.22M 10-Q · filed 2022-05-02 | $11.31M derived: sum of 2 quarters · filed 2023-03-01 | $15.93M derived: sum of 3 quarters · filed 2023-03-01 | $19.90M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $5.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $9.71M derived: sum of 2 quarters · filed 2023-03-01 | $13.68M derived: sum of 3 quarters · filed 2023-03-01 | $17.53M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $4.63M 10-Q · filed 2021-11-02 | $8.59M derived: sum of 2 quarters · filed 2021-11-02 | $12.44M 10-Q · filed 2021-11-02 | $15.40M derived: sum of 4 quarters · filed 2022-05-02 | ||
| 2020-06-30 | $3.97M 10-Q · filed 2021-08-03 | $7.82M 10-Q · filed 2021-08-03 | $10.78M derived: sum of 3 quarters · filed 2022-05-02 | $13.79M derived: sum of 4 quarters · filed 2022-05-02 | ||
| 2020-03-31 | $3.85M 10-Q · filed 2021-05-04 | $6.81M derived: sum of 2 quarters · filed 2022-05-02 | $9.83M derived: sum of 3 quarters · filed 2022-05-02 | $12.61M derived: sum of 4 quarters · filed 2022-05-02 | ||
| 2019-12-31 | $2.96M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-02 | $5.98M derived: sum of 2 quarters · filed 2022-05-02 | $8.76M derived: sum of 3 quarters · filed 2022-05-02 | $11.70M 10-K/A · filed 2022-05-02 | ||
| 2019-09-30 | $3.02M 10-Q · filed 2020-11-02 | $5.80M derived: sum of 2 quarters · filed 2020-11-02 | $8.74M 10-Q · filed 2020-11-02 | $12.51M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $2.78M 10-Q · filed 2020-08-04 | $5.72M 10-Q · filed 2020-08-04 | $9.49M derived: sum of 3 quarters · filed 2021-03-01 | $13.59M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $2.94M 10-Q · filed 2020-05-11 | $6.71M derived: sum of 2 quarters · filed 2021-03-01 | $10.80M derived: sum of 3 quarters · filed 2021-03-01 | $15.69M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $7.86M derived: sum of 2 quarters · filed 2021-03-01 | $12.75M derived: sum of 3 quarters · filed 2021-03-01 | $16.21M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $4.10M 10-Q · filed 2019-11-12 | $8.98M derived: sum of 2 quarters · filed 2019-11-12 | $12.44M 10-Q · filed 2019-11-12 | $15.07M derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2018-06-30 | $4.89M 10-Q · filed 2019-08-08 | $8.35M 10-Q · filed 2019-08-08 | $10.97M derived: sum of 3 quarters · filed 2020-03-03 | $14.39M derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2018-03-31 | $3.46M 10-Q · filed 2019-05-09 | $6.08M derived: sum of 2 quarters · filed 2020-03-03 | $9.50M derived: sum of 3 quarters · filed 2020-03-03 | $12.60M derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2017-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $6.04M derived: sum of 2 quarters · filed 2020-03-03 | $9.14M derived: sum of 3 quarters · filed 2020-03-03 | $12.15M 10-K · filed 2020-03-03 | ||
| 2017-09-30 | $3.42M 10-Q · filed 2018-11-13 | $6.51M derived: sum of 2 quarters · filed 2018-11-13 | $9.53M 10-Q · filed 2018-11-13 | |||
| 2017-06-30 | $3.09M 10-Q · filed 2018-08-14 | $6.11M 10-Q · filed 2018-08-14 | ||||
| 2017-03-31 | $3.01M 10-Q · filed 2018-05-10 | |||||
| 2016-12-31 | $13.90M 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM) | United States | $0.016B | -4.22 |
| Global Interactive Technologies, Inc. (GITS) | $0.008B | ||
| TaoWeave, Inc. (TWAV) | United States | $0.006B | |
| ZW Data Action Technologies Inc. (CNET) | $0.005B | -5.46 | |
| AIRWA INC. (YYAI) | United States | $0.004B | -101.45 |
| Teads Holding Co. (TEAD) | United States | $0.045B | -0.14 |
| Professional Diversity Network, Inc. (IPDN) | United States | $0.060B | |
| PodcastOne, Inc. (PODC) | United States | $0.068B | -42.98 |
| Eva Live Inc (GOAI) | United States | $0.083B | |
| Health Catalyst, Inc. (HCAT) | United States | $0.132B | -0.56 |